NCT03960775View on ClinicalTrials.gov

The Influence of Perioperative Administration of Dexmedetomidine on Inflammation Response and Postoperative Recovery in Patients Undergoing Robot or Laparoscopic Assisted Gastrectomy

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

November 29, 2019

Study Completion Date

November 29, 2019

Conditions
Gastric CancerGastrostomy
Interventions
DRUG

dexmedetomidine

Dexmedetomidine infusion (0.4㎍/kg/hr) from anesthetic induction until the start of closure of peritoneum.

DRUG

saline

Saline infusion during same time period.

Trial Locations (1)

03722

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03960775 - The Influence of Perioperative Administration of Dexmedetomidine on Inflammation Response and Postoperative Recovery in Patients Undergoing Robot or Laparoscopic Assisted Gastrectomy | Biotech Hunter | Biotech Hunter